|
KLF5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.335800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.588600E-01 |
| Normal-vs-Stage2 |
3.247800E-01 |
| Normal-vs-Stage3 |
8.782600E-01 |
| Normal-vs-Stage4 |
5.296400E-01 |
| Stage1-vs-Stage2 |
5.648500E-02 |
| Stage1-vs-Stage3 |
4.513600E-01 |
| Stage1-vs-Stage4 |
8.178000E-01 |
| Stage2-vs-Stage3 |
4.066000E-01 |
| Stage2-vs-Stage4 |
1.439640E-01 |
| Stage3-vs-Stage4 |
4.631800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.801000E-01 |
| Normal-vs-AfricanAmerican |
9.003200E-01 |
| Normal-vs-Asian |
5.843400E-01 |
| Caucasian-vs-AfricanAmerican |
5.934000E-01 |
| Caucasian-vs-Asian |
7.026000E-01 |
| AfricanAmerican-vs-Asian |
5.995000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.246000E-01 |
| Normal-vs-Female |
2.774000E-01 |
| Male-vs-Female |
3.690600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.336600E-01 |
| Normal-vs-Extreme_Weight |
9.073400E-01 |
| Normal-vs-Obese |
4.706600E-01 |
| Normal-vs-Extreme_Obese |
9.162400E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.200200E-01 |
| Normal_Weight-vs-Obese |
3.863400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.092840E-01 |
| Extreme_Weight-vs-Obese |
4.330600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.064100E-02 |
| Obese-vs-Extreme_Obese |
1.103670E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.339800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.876600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.146000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.919420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.218400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.899400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.706400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.229800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.036410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.850040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.593200E-01 |
| Normal-VS-Type2 PRCC |
7.504000E-02 |
| Normal-VS-KIRP CIMP |
7.682500E-03 |
| Normal-VS-Unclassified PRCC |
9.121200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.864400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.622270E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.595000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.57529999999762E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
9.879900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.617000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.487750E-01 |
| Normal-vs-N1 |
1.649010E-01 |
| Normal-vs-N2 |
4.375200E-01 |
| N0-vs-N1 |
6.240400E-03 |
| N0-vs-N2 |
1.429830E-01 |
| N1-vs-N2 |
9.847200E-01 |
|
|
